Sofie Baeten
CEO @ Qbic Fund
Ghent, Belgium
Sofie Baeten is a seed investor at Qbic Fund in Ghent focused on Life Science and Biotechnology. Sofie Baeten CEO Qbic II Fund. She attended KU Leuven.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 75%
Last updated:
For AI agents: llms.txt
Industries Sofie Baeten invests in
Stages Sofie Baeten invests in
Countries Sofie Baeten invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Life Science 1 (25%)
- Biotechnology 1 (25%)
- Semiconductor 1 (25%)
- Nanotechnology 1 (25%)
- Technical Support 1 (25%)
Stage
- Seed 2 (50%)
- Series A 1 (25%)
- Series B 1 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Animal Health Company | $11.8M / Series B / Jul 01, 2025 | ||
| AmphiStar is a biotechnology firm that makes sophorolipid products from biobased waste- and side streams. | $6.4M / Seed / Apr 18, 2024 | ||
| Animal Health Company | Series A / Nov 07, 2022 | ||
| QustomDot is an advanced materials company that produces on-chip grade Quantum Dots (QDs) and assists customers in successfully integrating QDs into their products. QustomDot is headquartered in Ghent, Belgium. | $3.3M / Seed / Feb 25, 2020 |
Co-Investors
About Qbic Fund
The Qbic Fund is a multi-sector fund supporting spin-off companies of the Ghent, Brussels and Antwerp university associations and of VITO. Through its strategic partnership with the universities of Ghent, Brussels and Antwerp, and VITO, the Qbic Fund has early and privileged access to promising research projects at these partner universities. Ourinvestment approach is based on early in-depth and independent review and analysis followed by hands on involvement and support.In May 2012 the Qbic Fund held its first close and currently it has over € 30 million under management. The Qbic Fund is backed by several public and private investors and managed by Qbic Venture Partners.
Qbic Fund Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Sofie Baeten
CEO
|
|||
Cedric Van Nevel
Investment Manager
|
|||
Danny Gonnissen
Venture Capital Fund Manager
|
|||
Steven Leuridan
Partner
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Sofie Baeten invest in?
Sofie Baeten invests primarily in Life Science, Biotechnology and Semiconductor startups, most often at Seed and Series A stage. Most of the 4 investments tracked by Shizune back companies in Belgium. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Sofie Baeten?
Public channels for Sofie Baeten include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Sofie Baeten last invest?
The most recent investment recorded for Sofie Baeten closed in Jul 2025. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
